Back
Sarepta Therapeutics 10K Form
Sell
48
SRPT
Sarepta Therapeutics
Last Price:
129.12
Seasonality Move:
17.56%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SRPT News And Ratings
See the #1 stock for the next 7 days that we like better than SRPT
SRPT Financial Statistics
Sales & Book Value
Annual Sales: | $1.24B |
---|---|
Cash Flow: | $-73.7M |
Price / Cash Flow: | 0 |
Annual Sales: | $9.17 |
Price / Book: | 14.22 |
Profitability
EPS (TTM): | -5.83000 |
---|---|
Net Income (TTM): | $-535.98M |
Gross Margin: | $1.09B |
Return on Equity: | -77.39% |
Return on Assets: | -17.08% |
Sarepta Therapeutics Earnings Forecast
Key Sarepta Therapeutics Financial Ratios
- The Gross Profit Margin over the past 28 years for SRPT is 87.91%.
- The Selling, General & Administrative Expenses for SRPT have been equal to 38.76% of Gross Profit Margin.
- The Research & Development expenses have been 70.57% of Revenue.
- The Interest Expense is -4.11% of Operating Income.
- The Net Earning history of SRPT is -43.11% of Total Revenues.
- Per Share Earnings over the last 28 years have been positive in 14 years.
Sarepta Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Healthcare |
Current Symbol: | SRPT |
CUSIP: | 803607 |
Website: | sarepta.com |
Debt
Debt-to-Equity Ratio: | 1.44 |
---|---|
Current Ratio: | 3.95 |
Quick Ratio: | 3.23 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 9.68 |
SRPT Technical Analysis vs Fundamental Analysis
Sell
48
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a Sell
The current Sarepta Therapeutics [SRPT] share price is $130.21. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.